GlassScriptPhysician profile
Ahmed Shim
NPI 1609273085
$42,810.04
in general payments reported to CMS, 2019-2025
17 companies · $586 in 2025
The $586 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $18K · 2021: $1,592 · 2022: $416 · 2023: $674 · 2024: $4,326 · 2025: $586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,265 · Food and Beverage: $2,322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,264.65 |
| Food and Beverage | $2,321.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $17,323.97 | 2019-2020 | |
| Boston Scientific Corporation | $13,202.36 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Watchman Flx, General - Ep |
| Medtronic, INC. | $5,542.82 | 2021-2025 | Micra, Cobalt Dr Mri Surescan, Aurora Ev-Icd Mri Surescan |
| Abbott Laboratories | $5,316.97 | 2019-2025 | Optis, Perclose Prostyle |
| Biosense Webster, INC. | $829.77 | 2021-2025 | Carto 3 |
| Biotronik INC. | $133.89 | 2021 | |
| Altathera Pharmaceuticals LLC | $118.55 | 2025 | Sotalol Hydrochloride |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $111.87 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $46.03 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.28 | 2024-2025 | Jardiance |
| Alnylam Pharmaceuticals INC. | $27.50 | 2019 | |
| Philips North America LLC | $24.80 | 2025 | Mcot |
| Novartis Pharmaceuticals Corporation | $22.92 | 2025 | |
| Janssen Pharmaceuticals, INC | $21.46 | 2024 | Xarelto |
| Pfizer INC. | $19.84 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elutia, INC. | $16.37 | 2022 | |
| Cardiva Medical, INC. | $13.64 | 2023 | Cardiva Vascade 6/7f Vcs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmed Shim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.